Shares outstanding decreased 7.6%
Shares outstanding changed -7.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -7.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Net income changed -83.1% from the comparable as-filed period.
Operating cash flow changed -62.5% from the comparable as-filed period.
Current ratio changed -16.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -23.4% from the comparable as-filed period.
Inventory / revenue changed +839 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -66.6% from the comparable as-filed period.
Operating cash flow changed -54.8% from the comparable as-filed period.
Cash & equivalents changed -26.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed -6.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Net income changed -75.5% from the comparable as-filed period.
Working capital changed -29.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capital expenditure changed +35.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.